Potential nanotechnology-based diagnostic and therapeutic approaches for Meniere's disease

Nanomedicine. 2022 Nov:46:102599. doi: 10.1016/j.nano.2022.102599. Epub 2022 Sep 5.

Abstract

Meniere's disease (MD) is a progressive inner ear disorder involving recurrent and prolonged episodes or attacks of vertigo with associated symptoms, resulting in a significantly reduced quality of life for sufferers. In most cases, MD starts in one ear; however, in one-third of patients, the disorder progresses to the other ear. Unfortunately, the etiology of the disease is unknown, making the development of effective treatments difficult. Nanomaterials, including nanoparticles (NPs) and nanocarriers, offer an array of novel diagnostic and therapeutic applications related to MD. NPs have specific features such as biocompatibility, biochemical stability, targetability, and enhanced visualization using imaging tools. This paper provides a comprehensive and critical review of recent advancements in nanotechnology-based diagnostic and therapeutic approaches for MD. Furthermore, the crucial challenges adversely affecting the use of nanoparticles to treat middle ear disorders are investigated. Finally, this paper provides recommendations and future directions for improving the performances of nanomaterials on theragnostic applications of MD.

Keywords: Meniere's disease; Nano-based hybrid systems; Nanoparticles; Nanotechnology; Theragnostic applications.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Meniere Disease* / complications
  • Meniere Disease* / diagnosis
  • Meniere Disease* / therapy
  • Nanotechnology
  • Quality of Life
  • Vertigo / complications